ArticleNature communications2017

A tetraoxane-based antimalarial drug candidate that overcomes PfK13-C580Y dependent artemisinin resistance.

Paul M O'Neill et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.